Growth Metrics

Repligen (RGEN) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Repligen (RGEN) over the last 7 years, with Q3 2025 value amounting to $139681.0.

  • Repligen's Gains from Sales and Divestitures rose 190.34% to $139681.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $139681.0, marking a year-over-year increase of 190.34%. This contributed to the annual value of $148429.0 for FY2024, which is 2414.4% down from last year.
  • As of Q3 2025, Repligen's Gains from Sales and Divestitures stood at $139681.0, which was up 190.34% from $122517.0 recorded in Q2 2025.
  • Repligen's Gains from Sales and Divestitures' 5-year high stood at $212329.0 during Q4 2021, with a 5-year trough of $98246.0 in Q1 2024.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $148429.0 (2024), whereas its average is $154545.2.
  • As far as peak fluctuations go, Repligen's Gains from Sales and Divestitures tumbled by 2414.4% in 2024, and later skyrocketed by 365.51% in 2025.
  • Over the past 5 years, Repligen's Gains from Sales and Divestitures (Quarter) stood at $212329.0 in 2021, then fell by 1.79% to $208531.0 in 2022, then fell by 6.17% to $195672.0 in 2023, then fell by 24.14% to $148429.0 in 2024, then fell by 5.89% to $139681.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $139681.0 for Q3 2025, versus $122517.0 for Q2 2025 and $101837.0 for Q1 2025.